Tezspire 210 MG/1.91 ML pen 1.91ML
Ended Awarded
- Contract number
- SPE2DB25FRRJ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,031
Award facts
- Contract value 100% obligated
- $7,030.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,030.77 to AmerisourceBergen Drug Corp for TEZSPIRE 210 mg/1.91 mL pen auto-injectors on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
TEZSPIRE is a specialty biologic medication used for moderate-to-severe eosinophilic asthma management and other eosinophilic conditions, representing part of the company's comprehensive pharmaceutical supply portfolio supporting military and federal healthcare systems. This delivery order exemplifies DLA's medical supply chain procurement model, under which AmerisourceBergen—a major pharmaceutical distributor—fulfills federal requirements for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The award demonstrates the contractor's ongoing capability to meet federal procurement standards through competitive processes and its critical role in supporting Defense Health Agency operations and military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB25FRRJ9?
SPE2DB25FRRJ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FRRJ9 worth?
The government has obligated $7,031 on SPE2DB25FRRJ9.
Is contract SPE2DB25FRRJ9 an order under another contract?
Yes. SPE2DB25FRRJ9 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRRJ9 competed?
The extent of competition for SPE2DB25FRRJ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award